Clinical Trials in Chicago

Showing 5241-5260 of 15,574 trials

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

NCT04696354

This clinical study is a global, prospective, multi-center, randomized controlled trial to determine if the use of intravascular ultrasound (IVUS) as an adjunctive imaging modality and as an interventional treatment guide will result in a more accurate diagnosis of deep vein occlusion (DVO), will guide optimal therapy, and will provide better clinical outcomes with reduced cost of care for patients presenting with persistent venous leg ulcers (VLUs).

Venous Ulcer of Leg

Philips Clinical & Medical Affairs Global12 participantsStarted Oct 2021

Darien, Connecticut, United States • Winter Park, Florida, United States • Chicago, Illinois, United States +14 more locations

TERMINATEDPhase 32.2 miles

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

NCT02548351

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Non Alcoholic Steatohepatitis (NASH)

Intercept Pharmaceuticals2,477 participantsStarted Sep 2015

Birmingham, Alabama, United States • Dothan, Alabama, United States • Chandler, Arizona, United States +343 more locations

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Find Trials by Condition in Chicago

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Open-Label Extension Study of Trofinetide for Rett Syndrome

Culturally Smart Relationships Study

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

Safety and Performance of PEEK Anchors in Extremities

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)